RT Journal Article
SR Electronic
T1 Deep Learning Prediction of Biomarkers from Echocardiogram Videos
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.03.21251080
DO 10.1101/2021.02.03.21251080
A1 J Weston Hughes
A1 Neal Yuan
A1 Bryan He
A1 Jiahong Ouyang
A1 Joseph Ebinger
A1 Patrick Botting
A1 Jasper Lee
A1 John Theurer
A1 James E. Tooley
A1 Koen Neiman
A1 Matthew P. Lungren
A1 David Liang
A1 Ingela Schnittger
A1 Bob Harrington
A1 Jonathan H. Chen
A1 Euan A. Ashley
A1 Susan Cheng
A1 David Ouyang
A1 James Y. Zou
YR 2021
UL http://medrxiv.org/content/early/2021/02/05/2021.02.03.21251080.abstract
AB Laboratory blood testing is routinely used to assay biomarkers to provide information on physiologic state beyond what clinicians can evaluate from interpreting medical imaging. We hypothesized that deep learning interpretation of echocardiogram videos can provide additional value in understanding disease states and can predict common biomarkers results. Using 70,066 echocardiograms and associated biomarker results from 39,460 patients, we developed EchoNet-Labs, a video-based deep learning algorithm to predict anemia, elevated B-type natriuretic peptide (BNP), troponin I, and blood urea nitrogen (BUN), and abnormal levels in ten additional lab tests. On held-out test data across different healthcare systems, EchoNet-Labs achieved an area under the curve (AUC) of 0.80 in predicting anemia, 0.82 in predicting elevated BNP, 0.75 in predicting elevated troponin I, and 0.69 in predicting elevated BUN. We further demonstrate the utility of the model in predicting abnormalities in 10 additional lab tests. We investigate the features necessary for EchoNet-Labs to make successful predictions and identify potential prediction mechanisms for each biomarker using well-known and novel explainability techniques. These results show that deep learning applied to diagnostic imaging can provide additional clinical value and identify phenotypic information beyond current imaging interpretation methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBH is supported by NSF - DGE-114747. DO is supported by American College of Cardiology / Merck Fellowship. JZ is supported by NSF - CCF 1763191, NIH R21 MD012867-01, NIH P30AG059307, and grants from the Silicon Valley Foundation and the Chan-Zuckerberg Initiative.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford IRB and Cedars-Sinai Medical Center IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the code for EchoNet-Labs will be available at https://github.com/echonet/ after publication. Matched laboratory values will be provided through our publicly available EchoNet dataset at https://echonet.github.io/. https://echonet.github.io/